Biocryst Pharmaceuticals Inc.

NASDAQ: BCRX    
Share price (5/3/24): $4.48    
Market cap (5/3/24): $924 million
Search in Documents
Key Exhibits
External Links
8 Biocryst Pharmaceuticals Inc. Expert Interviews, now on BamSEC.
 Powered by Tegus.

Underwriting Agreements Filter

EX-1.1
from 8-K 43 pages Biocryst Pharmaceuticals, Inc. 18,711,113 Shares of Common Stock (Par Value $0.01 Per Share) Pre-Funded Warrants to Purchase 3,511,111 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 39 pages Biocryst Pharmaceuticals, Inc. 37,931,035 Shares of Common Stock (Par Value $0.01 Per Share) Underwriting Agreement
12/34/56
EX-1.1
from 8-K 40 pages Biocryst Pharmaceuticals, Inc. 9,090,910 Shares of Common Stock (Par Value $0.01 Per Share) Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 2 pages Joint Filing Statement Pursuant to Rule 13d-1
12/34/56
EX-1.1
from 8-K 39 pages Biocryst Pharmaceuticals, Inc. 15,533,981 Shares of Common Stock (Par Value $0.01 Per Share) Underwriting Agreement
12/34/56
EX-1.1
from 8-K 37 pages Biocryst Pharmaceuticals, Inc. 5,294,118 Shares of Common Stock (Par Value $0.01 Per Share) Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 2 pages Joint Filing Statement Statement Pursuant to Rule 13d-1
12/34/56
EX-1
from SC 13G 2 pages Joint Filing Statement Statement Pursuant to Rule 13d-1
12/34/56
EX-1.1
from 8-K 38 pages Biocryst Pharmaceuticals, Inc. 10,000,000 Shares of Common Stock (Par Value $0.01 Per Share) Underwriting Agreement
12/34/56
EX-1.1
from 8-K 59 pages Biocryst Pharmaceuticals, Inc. 4,000,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 10-K 1 page March 11, 2013 MLV & Co. LLC 1251 Avenue of the Americas, 41st Floor New York, Ny 10020 Ladies and Gentlemen: Very Truly Yours, Biocryst Pharmaceuticals, Inc. By: Name: Title: Accepted as of the Date First-Above Written: MLV & Co. LLC By: Name: Dean Colucci Title: President
12/34/56
EX-1
from SC 13D/A 1 page Agreement
12/34/56
EX-1.2
from S-3 40 pages Biocryst Pharmaceuticals, Inc. Common Stock (Par Value $0.01 Per Share) at Market Issuance Sales Agreement
12/34/56
EX-1.1
from 8-K 30 pages 5,000,000 Shares Biocryst Pharmaceuticals, Inc. Common Stock, Par Value $0.01 Per Share Underwriting Agreement
12/34/56
EX-1
from SC 13D/A 1 page Agreement
12/34/56
EX-1
from SC 13D 1 page Exhibit 1 Agreement in Accordance With Rule 13d-1(k)(1) Under the Securities Exchange Act of 1934, as Amended, the Undersigned Hereby Agree That This Statement on Schedule 13d Relating to the Common Stock, $0.01 Par Value, of Biocryst Pharmaceuticals, Inc. Is Being Filed With the Securities and Exchange Commission on Behalf of Each of Them. October 13, 2005 By: /S/ Julian C. Baker Julian C. Baker By: /S/ Felix J. Baker Felix J. Baker Page 8 of 8
12/34/56
EX-1.1
from 8-K ~5 pages Placement Agency Agreemen
12/34/56
EX-1
from SC 13D/A 1 page Agreement Regarding Joint Filing
12/34/56
EX-1
from SC 13D 1 page Agreement Regarding Joint Filing
12/34/56
EX-1
from SC 13G/A ~1 page Agreement Regarding Joint Filing
12/34/56